Related Experiment Video
Updated: May 8, 2026

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
Incentivizing blood donation: systematic review and meta-analysis to test Titmuss' hypotheses
Claudia Niza1, Burcu Tung, Theresa M Marteau
1Department of Social Policy, London School of Economics, UK.
Insights
Paying blood donors may be economically inefficient, with limited evidence suggesting it does not improve donation quantity or quality. Further research is needed on incentive impacts.
Area of Science:
- Public Health
- Health Economics
- Blood Transfusion Services
Background:
- Richard Titmuss theorized that financial incentives for blood donation could decrease blood quality and be economically inefficient.
- This systematic review investigates the validity of Titmuss' hypotheses regarding incentives for blood donation.
Purpose of the Study:
- To systematically review evidence on the impact of financial and nonfinancial incentives on blood donation quantity and quality.
- To assess the economic efficiency and blood quality implications of incentivizing blood donors.
Main Methods:
- Systematic review of peer-reviewed, experimental studies comparing blood donation with and without incentives.
- Searched multiple databases including MEDLINE, EMBASE, PsycINFO, CINAHL, Cochrane Library, Econlit, JSTOR, and Google.
- Included studies involving 93,328 participants, analyzing data on donation quantity and quality.
Main Results:
- Incentives did not significantly impact the likelihood of blood donation (p = .19).
- No difference in blood donation quantity was observed between financial and nonfinancial incentives.
- Limited evidence on blood quality showed mixed results, with one study indicating an adverse effect from a cholesterol test incentive.
Conclusions:
- The findings partially support Titmuss' hypothesis regarding the economic inefficiency of incentives for blood donation.
- There is insufficient evidence to conclusively determine the impact of incentives on the quality of donated blood.
Objectives:
Titmuss hypothesized that paying blood donors would reduce the quality of the blood donated and would be economically inefficient. We report here the first systematic review to test these hypotheses, reporting on both financial and nonfinancial incentives.
Method:
Studies deemed eligible for inclusion were peer-reviewed, experimental studies that presented data on the quantity (as a proxy for efficiency) and quality of blood donated in at least two groups: those donating blood when offered an incentive, and those donating blood with no offer of an incentive. The following were searched: MEDLINE, EMBASE and PsycINFO using OVID SP, CINAHL via EBSCO and CENTRAL, the Cochrane Library, Econlit via EBSCO, JSTOR Health and General Science Collection, and Google.
Results:
The initial search yielded 1100 abstracts, which resulted in 89 full papers being assessed for eligibility, of which seven studies, reported in six papers, met the inclusion criteria. The included studies involved 93,328 participants. Incentives had no impact on the likelihood of donation (OR = 1.22 CI 95% 0.91-1.63; p = .19). There was no difference between financial and nonfinancial incentives in the quantity of blood donated. Of the two studies that assessed quality of blood, one found no effect and the other found an adverse effect from the offer of a free cholesterol test (β = 0.011 p < .05).
Conclusion:
The limited evidence suggests that Titmuss' hypothesis of the economic inefficiency of incentives is correct. There is insufficient evidence to assess their likely impact on the quality of the blood provided.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
